Results 81 to 90 of about 3,702 (95)

Editorial: Narrow the gap, build a bridge: an inspirational approach to chronic kidney disease-mineral and bone disorder. [PDF]

Curr Opin Nephrol Hypertens, 2022
Martin A, Isakova T.
europepmc   +1 more source

Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD). [PDF]

Cochrane Database Syst Rev
Natale P, Green SC, Ruospo M, Craig JC, Vecchio M, Elder GJ, Strippoli GF.   +6 more
europepmc   +1 more source

Pathophysiology of chronic kidney disease-mineral bone disorder (CKD-MBD): from adaptive to maladaptive mineral homeostasis. [PDF]

Clin Kidney J
Salera D, Merkel N, Bellasi A, de Borst MH.   +3 more
europepmc   +1 more source

Association between CKD-MBD and hip-bone microstructures in dialysis patients. [PDF]

Clin Kidney J
Iseri K, Mizobuchi M, Shishido K, Hida N.   +3 more
europepmc   +1 more source

New triple therapy for the diagnosis of CKD-MBD: a cross-sectional study in Shanxi province. [PDF]

BMJ Open
Zhao Z, Gao Y, Sui W, Zhang Z, Feng L, Wang Z, Yang D, Zhou Y, Li R, Huang B.   +9 more
europepmc   +1 more source

Clinical management of peripheral arterial disease in chronic kidney disease-a comprehensive review from the European Renal Association CKD-MBD Working Group. [PDF]

Clin Kidney J
Huish S, Nawaz S, Bellasi A, Diaz-Tocados JM, Haarhaus M, Sinha S.   +5 more
europepmc   +1 more source

Should We Consider the Cardiovascular System While Evaluating CKD-MBD? [PDF]

Toxins (Basel), 2020
Rroji M, Figurek A, Spasovski G.
europepmc   +1 more source

Klotho in pregnancy and intrauterine development-potential clinical implications: a review from the European Renal Association CKD-MBD Working Group. [PDF]

Nephrol Dial Transplant
Kanbay M, Mutlu A, Bakir CN, Peltek IB, Canbaz AA, Díaz Tocados JM, Haarhaus M.   +6 more
europepmc   +1 more source

Real-world usage of Chronic Kidney Disease - Mineral Bone Disorder (CKD-MBD) biomarkers in nephrology practices. [PDF]

Clin Kidney J
Fusaro M, Barbuto S, Gallieni M, Cossettini A, Re Sartò GV, Cosmai L, Cianciolo G, La Manna G, Nickolas T, Ferrari S, Bover J, Haarhaus M, Marino C, Mereu MC, Ravera M, Plebani M, Zaninotto M, Cozzolino M, Bianchi S, Messa P, Gregorini M, Gasperoni L, Agosto C, Aghi A, Tripepi G.   +24 more
europepmc   +1 more source

Corrigendum: Fucoidan ameliorates renal injury-related calcium-phosphorus metabolic disorder and bone abnormality in the CKD-MBD model rats by targeting FGF23-Klotho signaling axis. [PDF]

Front Pharmacol
Liu BH, Chong FL, Yuan CC, Liu YL, Yang HM, Wang WW, Fang QJ, Wu W, Wang MZ, Tu Y, Wan ZY, Wan YG, Wu GW.   +12 more
europepmc   +1 more source